SCIATIC DENERVATION-INDUCED SKELETAL MUSCLE ATROPHY IS ASSOCIATED WITH PERSISTENT INFLAMMATION AND INCREASED MORTALITY DURING SEPSIS
暂无分享,去创建一个
Yun-Gi Kim | Y. Enoki | K. Taguchi | M. Akiyama | Kazuaki Matsumoto | Yukio Fujiwara | Sumika Osa | Taichi Miyajima
[1] Shuangping Zhao,et al. Sarcopenia and Mortality Risk of Patients with Sepsis: A Meta-Analysis , 2022, International journal of clinical practice.
[2] L. Moldawer,et al. The impact of sarcopenia and acute muscle mass loss on long‐term outcomes in critically ill patients with intra‐abdominal sepsis , 2021, Journal of cachexia, sarcopenia and muscle.
[3] J. Andersen,et al. Muscle-nerve communication and the molecular assessment of human skeletal muscle denervation with aging. , 2021, American journal of physiology. Cell physiology.
[4] Wen-qing Xie,et al. Mouse models of sarcopenia: classification and evaluation , 2021, Journal of cachexia, sarcopenia and muscle.
[5] J. Ehmsen,et al. Cellular and molecular features of neurogenic skeletal muscle atrophy , 2020, Experimental Neurology.
[6] A. Hotz-Wagenblatt,et al. Skeletal muscle antagonizes antiviral CD8+ T cell exhaustion , 2020, Science Advances.
[7] Niranjan Kissoon,et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study , 2020, The Lancet.
[8] S. Meuth,et al. Skeletal muscle as potential central link between sarcopenia and immune senescence , 2019, EBioMedicine.
[9] R. Gómez,et al. Platelets Promote Macrophage Polarization toward Pro-inflammatory Phenotype and Increase Survival of Septic Mice. , 2019, Cell reports.
[10] Tadaaki Yamada,et al. Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer , 2019, Journal of clinical medicine.
[11] J. Vincent,et al. Mechanisms and treatment of organ failure in sepsis , 2018, Nature Reviews Nephrology.
[12] G. Regolisti,et al. Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury , 2018, Journal of Nephrology.
[13] F. Venet,et al. Advances in the understanding and treatment of sepsis-induced immunosuppression , 2018, Nature Reviews Nephrology.
[14] D. Gabrilovich,et al. Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.
[15] Derek C. Angus,et al. Enhancing Recovery From Sepsis: A Review , 2018, JAMA.
[16] R. De Gasperi,et al. Denervation-related alterations and biological activity of miRNAs contained in exosomes released by skeletal muscle fibers , 2017, Scientific Reports.
[17] M. Netea,et al. The immunopathology of sepsis and potential therapeutic targets , 2017, Nature Reviews Immunology.
[18] M. Otagiri,et al. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1 , 2016, Scientific Reports.
[19] A. Zwinderman,et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. , 2016, Blood.
[20] S. Inoue,et al. Sepsis induces incomplete M2 phenotype polarization in peritoneal exudate cells in mice , 2016, Journal of Intensive Care.
[21] Y. Maehara,et al. Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[22] M. Otagiri,et al. Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury , 2015, PloS one.
[23] K. Hozumi,et al. Persistent inflammation and T cell exhaustion in severe sepsis in the elderly , 2014, Critical Care.
[24] Q. Shu,et al. Myeloid-Derived Suppressor Cells in Sepsis , 2014, BioMed research international.
[25] Chibeza C. Agley,et al. Acute skeletal muscle wasting in critical illness. , 2013, JAMA.
[26] R. Hotchkiss,et al. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. , 2013, The Lancet. Infectious diseases.
[27] M. Sandri,et al. Cellular and molecular mechanisms of muscle atrophy , 2013, Disease Models & Mechanisms.
[28] M. Rose,et al. Quality of life and measures of quality of life in patients with neuromuscular disorders , 2012, Muscle & nerve.
[29] L. Moldawer,et al. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.
[30] John D. Storey,et al. A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.
[31] L. Moldawer,et al. Cecal Ligation and Puncture , 2010, Current protocols in immunology.
[32] D. Denhardt,et al. Osteopontin regulates hindlimb-unloading-induced lymphoid organ atrophy and weight loss by modulating corticosteroid production , 2007, Proceedings of the National Academy of Sciences.
[33] M. Heiman,et al. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis , 2003, Analytical and bioanalytical chemistry.
[34] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .